Peer review process

This article was accepted for publication via eLife's original publishing model. eLife publishes the authors' accepted manuscript as a PDF only version before the full Version of Record is ready for publication. Peer reviews are published along with the Version of Record.

History

  1. Version of Record updated
  2. Version of Record published
  3. Accepted Manuscript published
  4. Accepted
  5. Received

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Sébastien Jeay
  2. Swann Gaulis
  3. Stéphane Ferretti
  4. Hans Bitter
  5. Moriko Ito
  6. Thérèse Valat
  7. Masato Murakami
  8. Stephan Ruetz
  9. Daniel A Guthy
  10. Caroline Rynn
  11. Michael R Jensen
  12. Marion Wiesmann
  13. Joerg Kallen
  14. Pascal Furet
  15. François Gessier
  16. Philipp Holzer
  17. Keiichi Masuya
  18. Jens Würthner
  19. Ensar Halilovic
  20. Francesco Hofmann
  21. William R Sellers
  22. Diana Graus Porta
(2015)
A distinct p53 target gene set predicts for response to the selective p53-HDM2 inhibitor NVP-CGM097
eLife 4:e06498.
https://doi.org/10.7554/eLife.06498

Share this article

https://doi.org/10.7554/eLife.06498